Virginia Beach, VA – January 21, 2025 – LifeNet Health proudly announces the launch of PliaFX® Flo, an innovative addition to its PliaFX portfolio of advanced fiber demineralized bone matrices. With "natural fusion, perfected" as its guiding principle, PliaFX Flo is engineered to amplify healing potential, delivering greater confidence to surgeons and better outcomes for patients. This next-generation bone void solution, now in a pre-filled syringe format, offers surgeons enhanced precision and handling, streamlining its application for spine and orthopedic procedures.

Built using LifeNet Health’s proprietary PliaFX Advanced Fiber technology, PliaFX Flo combines the strength of natural bone with unmatched handling and moldability. Its unique microhook fiber structure is crafted to promote a natural fusion process, optimizing the body’s regenerative response while supporting reliable integration and retention.

"PliaFX fibers have been transformative for my patients’ outcomes. The syringe format of PliaFX Flo enhances its application, making it easier to achieve precise and efficient placement, even in complex cases," said Dr. Byron Branch, a neurosurgeon experienced in using PliaFX fibers.

The new syringe format further enhances the product's ease of use, allowing for efficient, one-step application that reduces OR preparation time. This detail underscores LifeNet Health’s commitment to advancing grafting solutions that prioritize both surgical precision and patient well-being.

PliaFX Flo is available through Johnson & Johnson MedTech and the LifeNet Health Orthobiologics strategic services team, strengthening a shared mission both organizations have to drive forward surgical advancements and transform patient care globally.

PliaFX Flo is the latest addition to the PliaFX family, which includes PliaFX Prime—the premier 100% bone fiber Demineralized Bone Matrix (DBM) —and PliaFX Pak, which extends a full spectrum of grafting options. PliaFX Pak, released in the summer of 2024 has quickly gained enthusiastic adoption, offers a DBM blend with bone chips for filling large voids, ensuring exceptional handling and hemostatic properties that adapt to various surgical needs.

"With PliaFX Flo, we are expanding the possibilities for fusion, making natural healing more efficient than ever," said Richard Rice, Vice President of Orthopedics and CMF at LifeNet Health. "Our fiber technology provides a uniquely natural, versatile approach to bone fusion, delivering surgeons a new level of control and effectiveness in the operating room."

PliaFX Flo is now available. To learn more, please visit www.lifenethealth.org/flo.

About LifeNet Health

LifeNet Health is a global leader in regenerative medicine, providing a comprehensive range of transplant solutions from organ procurement to bio-implants and cellular therapies. LifeNet Health’s mission is to improve the quality of human life by advancing medical possibilities in transplantation and research.

About Johnson & Johnson MedTech

Johnson & Johnson MedTech is a global innovator in medical technology, dedicated to enhancing healthcare quality and patient outcomes worldwide through advanced solutions that address critical surgical and medical needs.

PliaFX® and LifeNet Health® are registered trademarks of LifeNet Health.